naphazoline has been researched along with Migraine Disorders in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Novak, VJ | 1 |
1 other study available for naphazoline and Migraine Disorders
| Article | Year |
|---|---|
Pathogenesis and surgical therapy of migraine attacks caused by weather (Foehn) and menstruation.
Topics: Adolescent; Adult; Drug Combinations; Female; Humans; Male; Menstruation; Middle Aged; Migraine Diso | 1984 |